The WTO approved a deal yesterday to let poorer nations import cheaper generic drugs to fight killer diseases such as AIDS and malaria after days of emotionally charged debate.
The deal plugs a gap in world trade law and allows poorer countries unable to manufacture medicines domestically to override international patents and import cheap generic drugs when they need to.
"The decision that you have just taken is an historic agreement for the WTO," WTO Director-General Supachai Panitchpakdi told member states.
The accord, given a final seal of approval by the WTO's 146-member executive General Council yesterday, means setting aside patents owned by multinational firms that are protected by trade rules.
"I find a special satisfaction in the fact that the decision will be of particular value to the smaller and poorer countries ... in Africa and elsewhere," Supachai said. "It will enable them to make full use of the flexibilities in the WTO intellectual property rules in order to deal with the diseases that ravage their peoples."
An impassioned plea on Friday by African states, who said that thousands were dying as trade envoys bickered, got the talks back on track after a deal agreed on Thursday by the main negotiating body on medicines ran into last-minute problems.
Oppostion
But health activists attacked the accord, hammered out by the US, Brazil, India, Kenya and South Africa, saying it imposed too many conditions on countries seeking to use it.
"Today's WTO agreement that is ostensibly intended to get drugs to the poorest countries does not provide a workable solution," Medicines sans Frontieres (Doctors without Borders) and Oxfam said in a joint statement.
The pact aims to allay US concerns that any waiving of patents could be abused for commercial gain by generic producers such as Brazil and India.
The US, home to many major pharmaceutical firms, had feared they could turn out highly profitable life-style remedies such as Viagra for sale in richer developing nations.
The drugs industry has welcomed the pact as balancing the need for poor states to fight health problems with the demands that WTO members waive patents only to import generic medicines "in good faith" and do not abuse the system for commercial gain.
Steps will be taken to ensure medicine sold to poor countries does not turn up on rich country markets, and a number of richer developing countries -- such as Mexico and South Korea -- will agree to use the system only in dire health emergencies.
Existing world trade rules allowed countries -- developed or developing -- with their own drugs industry to waive patents and issue compulsory licences to generic manufacturers when they face health emergencies.
But the regulations said nothing about states without their own drugs industry and WTO states have been battling over the issue for nearly two years.
A deal before a trade meeting in the Mexican resort of Cancun in less than two weeks was seen as vital to giving new momentum to the WTO's struggling Doha Round of free trade talks.
purpose: Tesla’s CEO sought to meet senior Chinese officials to discuss the rollout of its ‘full self-driving’ software in China and approval to transfer data they had collected Tesla Inc CEO Elon Musk arrived in Beijing yesterday on an unannounced visit, where he is expected to meet senior officials to discuss the rollout of "full self-driving" (FSD) software and permission to transfer data overseas, according to a person with knowledge of the matter. Chinese state media reported that he met Premier Li Qiang (李強) in Beijing, during which Li told Musk that Tesla's development in China could be regarded as a successful example of US-China economic and trade cooperation. Musk confirmed his meeting with the premier yesterday with a post on social media platform X. "Honored to meet with Premier Li
Dutch brewing company Heineken NV on Friday announced an investment of NT$13.5 billion (US$414.62 million) over the next five years in Taiwan. The first multinational brewing company to operate in Taiwan, Heineken made the statement at a ceremony held at its brewery in Pingtung County. It also outlined its efforts to make the brewery “net zero” by 2030. Heineken has been in the Taiwanese market for 20 years, Heineken Taiwan managing director Jeff Wu (吳建甫) said. With strong support from local consumers, the Dutch brewery decided to transition from sales to manufacturing in the country, Wu said. Heineken assumed majority ownership and management rights
ARTIFICIAL INTELLIGENCE: The chipmaker last month raised its capital spending by 28 percent for this year to NT$32 billion from a previous estimate of NT$25 billion Contract chipmaker Powerchip Semiconductor Manufacturing Corp (力積電子) yesterday launched a new 12-inch fab, tapping into advanced chip-on-wafer-on-substrate (CoWoS) packaging technology to support rising demand for artificial intelligence (AI) devices. Powerchip is to offer interposers, one of three parts in CoWoS packaging technology, with shipments scheduled for the second half of this year, Powerchip chairman Frank Huang (黃崇仁) told reporters on the sidelines of a fab inauguration ceremony in the Tongluo Science Park (銅鑼科學園區) in Miaoli County yesterday. “We are working with customers to supply CoWoS-related business, utilizing part of this new fab’s capacity,” Huang said, adding that Powerchip intended to bridge
Microsoft Corp yesterday said that it would create Thailand’s first data center region to boost cloud and artificial intelligence (AI) infrastructure, promising AI training to more than 100,000 people to develop tech. Bangkok is a key economic player in Southeast Asia, but it has lagged behind Indonesia and Singapore when it comes to the tech industry. Thailand has an “incredible opportunity to build a digital-first, AI-powered future,” Microsoft chairman and chief executive officer Satya Nadella said at an event in Bangkok. Data center regions are physical locations that store computing infrastructure, allowing secure and reliable access to cloud platforms. The global embrace of AI